MILLWAY MEDICAL PRACTICE — All Prescriptions & Medications — Page 14
Practice Code: E83016 | LONDON, NW7 2HX
Showing results 651-700 of 717
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Promazine hydrochloride | 13 | 3,900 | £1.6K | -75.4% ▼ |
| Medroxyprogesterone acetate | 13 | 13 | £75 | -89.2% ▼ |
| Prednisolone sodium phosphate | 13 | 600 | £382 | +1.9% vs avg |
| Calamine | 13 | 3,200 | £23 | +71.5% ▲ |
| Ketoconazole | 13 | 420 | £57 | +30.7% ▲ |
| 13 | 130 | £172 | -36.2% ▼ | |
| 13 | 460 | £350 | -50.1% ▼ | |
| Cimetidine | 12 | 1,094 | £111 | -35.7% ▼ |
| Torasemide | 12 | 336 | £114 | +6.9% ▲ |
| INR blood testing reagents | 12 | 288 | £820 | +59.3% ▲ |
| Eletriptan | 12 | 96 | £342 | +21.5% ▲ |
| Urine testing reagents | 12 | 600 | £34 | +7.3% ▲ |
| Phentolamine/aviptadil | 12 | 60 | £570 | +68.1% ▲ |
| Mercaptopurine | 12 | 636 | £293 | -22.5% ▼ |
| Methotrexate | 12 | 48 | £766 | -59.8% ▼ |
| Powder 2 kcal/ml m/sk higher volume, higher energy (0913011) | 12 | 598 | £2.1K | +20.8% ▲ |
| RtS extensively hydrolysed formula, high energy (0913103) | 12 | 134.0K | £3.4K | +109.6% ▲ |
| Ready to serve infant formula, high energy (0913104) | 12 | 177.8K | £2.2K | +8.6% ▲ |
| Azelastine hydrochloride | 12 | 136 | £104 | +1.0% vs avg |
| Malathion | 12 | 3,150 | £292 | +87.9% ▲ |
| Other individually formulated bought in preparations | 12 | 974 | £444 | -63.3% ▼ |
| 12 | 87 | £348 | -12.0% ▼ | |
| 12 | 63 | £71 | -63.4% ▼ | |
| 12 | 140 | £404 | +90.2% ▲ | |
| 12 | 550 | £104 | -62.2% ▼ | |
| 12 | 450 | £396 | -70.4% ▼ | |
| Prednisolone sodium phosphate | 11 | 268 | £6.8K | +182.9% ▲ |
| Chlorothiazide | 11 | 1,800 | £367 | +98.2% ▲ |
| Dronedarone hydrochloride | 11 | 1,560 | £1.7K | -23.9% ▼ |
| Hyoscine | 11 | 111 | £715 | +58.5% ▲ |
| Doxylamine succinate/pyridoxine hydrochloride | 11 | 190 | £271 | -0.3% vs avg |
| Metformin hydrochloride/sitagliptin | 11 | 1,400 | £245 | -70.6% ▼ |
| Dienogest | 11 | 1,148 | £799 | +51.9% ▲ |
| Clindamycin phosphate | 11 | 440 | £114 | +163.7% ▲ |
| Metronidazole | 11 | 480 | £49 | +66.3% ▲ |
| Dronabinol/cannabidiol | 11 | 2,970 | £3.3K | +46.0% ▲ |
| Diethylamine salicylate | 11 | 1,100 | £34 | -59.3% ▼ |
| Piroxicam | 11 | 1,048 | £27 | -80.9% ▼ |
| 11 | 175 | £477 | -48.0% ▼ | |
| 11 | 160 | £574 | -66.2% ▼ | |
| 11 | 95 | £69 | +37.6% ▲ | |
| 11 | 38 | £1.3K | +33.6% ▲ | |
| 11 | 140 | £288 | -6.7% ▼ | |
| 11 | 14 | £729 | +164.5% ▲ | |
| 11 | 900 | £110 | -94.9% ▼ | |
| 11 | 700 | £2.2K | +25.5% ▲ | |
| Perindopril arginine | 10 | 300 | £101 | -15.4% ▼ |
| Valsartan with diuretic | 10 | 476 | £309 | -24.5% ▼ |
| Valsartan/amlodipine | 10 | 560 | £431 | -8.8% ▼ |
| Citalopram hydrochloride | 10 | 195 | £128 | -37.7% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.